Project Assistant

Tamera B. Gooding, M.S.

. Self-motivated, enthusiastic, dedicated individual with 14 years of

hands-on industry experience developing a variety of formulations.

. Experienced in cultivating prototypes from conception,

characterization, formulation optimization, and process transfer

through to scale-up for pre-clinical and clinical material

preparation. Competently analyzing, organizing, and communicating

progress and data to project teams. Throughout all phases

successively collaborating with engineers, QA, QC, CA, and RA while

generating required documentation.

. Excellent at resolving simple and complex formulation problems

using professional knowledge.

. Exceptional attention to detail, organization and communication.

. Strong initiation, enthusiasm and determination in learning.

. Molecular weight

. Light scattering

. Gel electrophoresis

. Western Blot analysis

. Chromatography: column, thin layer, size exclusion, gel

permeation, ion exchange, reversed-phased, gas

. HPLC

. Organic synthesis & purification

. Organic spectroscopy: 1H & 13C NMR

. Spectrophotometry: UV/Vis, infrared

. Sterilization technology

. Lyophilization

. Dissolution

. Homogenization

. Sonication

. Osmometry

. Particle size analysis

. Karl Fischer

. Microscopy

. Biostatistics

. GxP experience

M.S. in Pharmaceutics and Drug Delivery Systems, GPA 3.70, 2012

NORTHEASTERN UNIVERSITY, Boston, MA

B.S. in Biochemistry, 1998

SIMMONS COLLEGE, Boston, MA

NORTHEASTERN UNIVERSITY, Department of Pharmaceutical Sciences

May 2012 - August 2012

Boston, MA

Directed Study

. Directed study in developing a target specific polymeric micelle co-

loaded with two anti-cancer agents and modified with an anti-Glut-1

antibody for specific adenocarcinoma targeting.

EUROPEAN CONTINUING EDUCATION COLLEGE

April 2012 London,

UK

Parenteral Products Course

. Formulation of sterile products and the effect on bioavailability,

toxicity, physical and chemical stability, route of administration

and shelf life.

ANIKA THERAPEUTICS, INC., Product Development

Bedford, MA

October 1999 - Present

Senior Scientist

. Responsible for strategy, execution, and analysis of new product

formulations to support preclinical and clinical product

development.

. Design, prepare material, conduct, and write reports on preliminary

stability testing and pre-clinical studies.

. Support the development and implementation of analytical methods

used for testing.

. Oversee technology transfer of formulation process to pilot scale-

up for verification, validation, stability and clinical studies.

. Collect, document, analyze, and organize data on projects

independently and communicate updates to superiors, project teams,

and in presentations.

. Contribute R&D expertise by participating in strategic and

scientific planning while providing technical and problem-solving

input with formulation related challenges.

. Prepare documentation in accordance with current industry and

company standards.

HARVARD UNIVERSITY, Department of Cancer Cell Biology

Boston, MA

September 1996 - October 1999

Research Assistant

. Investigated effects of ionizing radiation on human cells in

culture.

. Using aseptic technique cultured and counted cells to prepare for

lysis, extracted and quantified proteins using UV-Vis

spectrophotometry separated proteins by gel electrophoresis and

analyzed by western blot analysis using chemiluminescence detection

and autoradiography.

. Prepared reports, presentations and data for publication.

. Tamera B. Gooding, Stephen J. Kennedy, Charles H. Sherwood.

Treatment of arthritis and other musculoskeletal disorders with

cross-linked hyaluronic acid. Patent. 2012.

. Tamera B. Gooding, Khalid K. Sadozai, Kyle Bui, Charles H.

Sherwood. Cross-linked hyaluronic acid compositions for tissue

augmentation. Patent. 2012.

. Ayako Honda, Annise Berger, Tamera B. Gooding and Nancy E. Lee.

Stereoselective reduction of steroidal side chains containing

alkynone system. Journal of Undergraduate Chemistry Research. 2005;

4, 123.

. S.M. de Toledo, E.I. Azzam, W.K. Dahlberg, T.B. Gooding and J.B.

Little. ATM complexes with HDM2 and promotes its rapid

phosphorylation in a p53-independent manner in normal and tumor

human cells exposed to ionizing radiation. Oncogene. 2000; 19, 6185-

6193.

. E.I. Azzam, S.M. de Toledo, T.B. Gooding and J.B. Little.

Intercellular communication is involved in the bystander regulation

of gene expression in human cells exposed to very low fluences of

alpha particles. Radiation Research. 1998; 150, 497-505.

References available upon request

Summary

Skills

Education

Academic

Experience

Industry

Experience/

Employment

Patents

Publications

Contact this candidate